InGel Therapeutics
PrivateLast Round
Grant
Dec 2, 2024
Total Funding Raised
$13.48M
Company Overview
InGel Therapeutics is a biotechnology company developing engineered cell therapies designed to target neuroprotective pathways to treat retinal degeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InGel Therapeutics Comparables
Compare InGel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| jCyte, Inc. | 85% | |
| Nanoscope Therapeutics Inc. | 82% | |
| Agnos Therapeutics | 81% | |
InGel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 2, 2024 | ||||
| Seed | Jul 1, 2024 | ||||
| Grant | May 4, 2023 | ||||
| Accelerator | Sep 1, 2022 |
Key People
Founding team and executive leadership
InGel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bertarelli Foundation | Grant |
| ARPA-H | Grant |
| The Venture Collective | Seed |
| Nucleate | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Monthly visitors grew 51% MoM, from 885 to 1.3K.
- Jul 8, 2025
Monthly visitors increased 45% MoM.
InGel Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about InGel Therapeutics's valuation, stock price, and market status.